A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients.

Giraudet, Anne-Laure; Cassier, Philippe Alexandre; Iwao-Fukukawa, Chicaco; Garin, Gwenaelle; Badel, Jean-Noël; Kryza, David; Chabaud, Sylvie; Gilles-Afchain, Laurence; Clapisson, Gilles; Desuzinges, Claude; Sarrut, David; Halty, Adrien; Italiano, Antoine; Mori, Masaharu; Tsunoda, Takuya; Katagiri, Toyomasa; Nakamura, Yusuke; Alberti, Laurent; Cropet, Claire; Baconnier, Simon; Berge-Montamat, Sandrine; Pérol, David; Blay, Jean-Yves.
BMC Cancer; 18(1): 646, 2018 Jun 08.
Artigo em Inglês | MEDLINE | ID: mdl-29884132